1. Home
  2. ERII vs ANL Comparison

ERII vs ANL Comparison

Compare ERII & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Recovery Inc.

ERII

Energy Recovery Inc.

HOLD

Current Price

$9.39

Market Cap

595.9M

Sector

Technology

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$13.95

Market Cap

703.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERII
ANL
Founded
1992
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
595.9M
703.3M
IPO Year
2008
2022

Fundamental Metrics

Financial Performance
Metric
ERII
ANL
Price
$9.39
$13.95
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$17.07
$20.00
AVG Volume (30 Days)
721.9K
652.4K
Earning Date
05-06-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
5.00
N/A
EPS
N/A
N/A
Revenue
$134,987,000.00
N/A
Revenue This Year
N/A
$36.02
Revenue Next Year
$20.55
N/A
P/E Ratio
$27.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.35
$0.88
52 Week High
$18.31
$17.25

Technical Indicators

Market Signals
Indicator
ERII
ANL
Relative Strength Index (RSI) 34.85 53.54
Support Level N/A $1.36
Resistance Level $11.54 $17.25
Average True Range (ATR) 0.49 1.73
MACD -0.04 -0.28
Stochastic Oscillator 3.51 42.26

Price Performance

Historical Comparison
ERII
ANL

About ERII Energy Recovery Inc.

Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: